Metrics as of 10/14/2026, 07:19 AM (Berlin time), refresh in progress.
NIOX Group Stock
NIOX Group Plc
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United Kingdom
- CEO
- Jonathan Charles Emms
- Employees
- 97
- Market cap
- £278 M
- IPO
- 13/03/2014
- Web
- www.niox.com
NIOX Group Plc is a worldwide company dedicated to innovating, developing, and distributing medical devices that measure fractional exhaled nitric oxide (FeNO). A key product is the NIOX VERO system, an easily portable and non-invasive diagnostic tool designed for immediate, on-site patient use. This system includes a…
NIOX Group stock: price history
1D
-1.7%
1W
+0.6%
1M
+2.7%
6M
+18.9%
YTD
+2.1%
1Y
-10.8%
2Y
-2.3%
5Y
+47.9%
10Y
-23.8%
Next earnings date
Next earnings date
23/03/2027 (in 157 days)
Volatility around earnings
~27% weaker price swings than usual
Ask the agents about NIOX Group
NIOX Group stock metrics
P/E
39.52
P/B
4.19
EV/EBITDA
17.8
RETURN ON EQUITY
8.9%
NET MARGIN
24.6%
DEBT/EQUITY
0.01
DIVIDEND YIELD
2.3%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
78.2%
FLOAT SHARES
329,248,389
AVG. DAILY VOLUME (30D)
515,665
Dividends
Comparable stocks
Frequently asked questions about NIOX Group stock
What does NIOX Group do?
NIOX Group Plc is a company in the Healthcare sector, Medical - Devices industry, headquartered in United Kingdom.
The CEO is Jonathan Charles Emms, the company employs around 97 people.
The IPO was on 13/03/2014; the stock trades on LSE under the ticker NIOX.L.
When does NIOX Group report next?
The next earnings date is 23/03/2027.
Around past earnings, price swings were roughly -27% stronger than usual.
Does NIOX Group pay a dividend?
Yes. The last dividend was £1.55 per share, ex-date 21/05/2026, paid on 22/06/2026.
The dividend yield is 2.3% (as of 30/06/2026).
Which stocks are comparable to NIOX Group?
Comparable stocks include Smith & Nephew, LivaNova, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and Siemens Healthineers.
How can I get NIOX Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess NIOX Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.